Processing Your Payment

Please do not leave this page until complete. This can take a few moments.

May 9, 2007

Loss widens for drug co.

Indevus Pharmaceuticals Inc. of Lexington reported first quarter revenue of $11.2 million, and a $12.4 million net loss.

During the same period the previous year, the company reported revenue of $14.4 million and a net loss of $11.2 million.

For the six months ended March 31, Indevus reported revenue of $24.4 million and a net loss of $23.2 million.

The company acquired Valera Pharmaceuticals in April.

Indevus acquires, researches and develops urology and endocrinology drugs.

Sign up for Enews

WBJ Web Partners

0 Comments

Order a PDF